JANSSEN-CILAG LIMITED

PaymentCheck Score 2025
65Fair
1.8vs last year
#2768 in UK
#41 in Life Sciences And Medical Technology
#459 in South East

Company Information

Company Number
01027904
Registered Address
50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG
Status
Active
Employee Count
1,090
Turnover
£637,412,000
EBITDA
£62,190,000

Additional Details

Company Type
Private limited Company
Incorporated On
19 October 1971
Nature of Business
21200 - Manufacture of pharmaceutical preparations
Industries
Life Sciences And Medical Technology
Region
South East

Time to Pay

Average Time to Pay
36 days
Shortest Period:45 days
Longest Period:60 days
Max Contractual:90 days

Payment Timeline

Within 30 Days
45%
31-60 Days
36%
After 60 Days
19%
Not Paid Within Terms14%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Performance Reports History

Reporting Period Filed: 2025-07-31
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jan 2025 - 30 Jun 202531 Jul 20253645%36%19%14%
01 Jul 2024 - 31 Dec 202405 Feb 20253546%35%19%9%
01 Jul 2023 - 31 Dec 202306 Mar 20243843%36%21%8%
01 Jan 2023 - 30 Jun 202306 Mar 20243646%30%24%13%
30 Jun 2022 - 31 Dec 202230 Nov 20234536%32%33%8%
01 Jan 2022 - 30 Jun 202209 Sept 20224436%34%30%8%
30 Jun 2021 - 31 Dec 202125 Jan 20224234%40%25%12%
01 Jan 2020 - 30 Jun 202029 Jul 20203836%47%16%20%
01 Jan 2019 - 30 Jun 201929 Jul 20192960%36%4%28%
01 Jul 2018 - 31 Dec 201828 Jan 20193058%38%4%21%
01 Jan 2018 - 30 Jun 201825 Jul 20183157%37%6%27%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

45 or 60 days twice monthly

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

No additional information

Maximum contractual payment period agreed

90

Dispute Resolution Process

Invoices in dispute or held for payment are managed via ERP system workflow with automated communication to the supplier providing details and advice about the reason for dispute. Global Services Accounts Payable team support dispute resolution and maintain on-time payment SLA's. Suppliers can contact J&J Customer Service for assistance and support with invoice or payment queries or view invoice payment status via the J&J online Supplier Portal.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

JANSSEN-CILAG LIMITED is a pharmaceutical company that focuses on improving the health and well-being of people around the world. The company is a part of the global healthcare company, Johnson & Johnson, and has been in operation since 1957.

The company's sustainability program, called "Healthy Future 2025," aims to reduce their environmental impact and promote sustainable practices in their operations. This includes goals such as reducing carbon emissions and water usage, as well as increasing the use of renewable energy sources.

JANSSEN-CILAG LIMITED offers a wide range of products and services in various therapeutic areas such as oncology, immunology, and infectious diseases. Their products include prescription medicines, over-the-counter medicines, and medical devices. The company also provides medical education and support programs for healthcare professionals and patients.

Some key people in JANSSEN-CILAG LIMITED include Richard Saynor, the Managing Director, and Dr. Louisa M. Nelson, the Medical Director. They lead a team of dedicated employees who are committed to the company's mission of improving global health.

The company's website address is www.janssen.com/uk and their registered office address is 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, United Kingdom. JANSSEN-CILAG LIMITED can also be contacted through their customer service hotline at 0808 238 9999.

Financial Metrics

Cash
£20,751,000
Net Worth
£142,956,000
Total Current Assets
£323,574,000
Total Current Liabilities
£302,138,000

Company Location